4//SEC Filing
Chu Yu-Waye 4
Accession 0001209191-23-007497
CIK 0001434316other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:13 PM ET
Size
5.5 KB
Accession
0001209191-23-007497
Insider Transaction Report
Form 4
Chu Yu-Waye
Senior VP Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2023-02-06+425,000→ 425,000 totalExercise: $6.77Exp: 2033-02-05→ Common Stock (425,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2023, such that all of the shares shall be fully vested and exercisable on January 1, 2026, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001854586
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:13 PM ET
- Size
- 5.5 KB